Description of Collaborative Activity: |
Stem cells have the potential to treat many diseases, including eye diseases. On December 5-6, 2016, the National Eye Institute (NEI) convened 75 leading stem cell researchers, clinicians, and relevant stakeholders from private foundations, the Food and Drug Administration (FDA) and the National Institutes of Health (NIH), to discuss the state of the science, progress, challenges, and the pathways necessary to translate the science and technology of stem cells to clinical trials for therapy. Cell types discussed included bone marrow (BMSCs), adult stem cells, embryonic (ESCs), corneal limbal stem cells, neural, and retinal progenitors and induced pluripotent stem cells (iPSCs). |
